barre

A New Antibiotic to the Rescue?

THURSDAY, June 16, 2016 (HealthDay News) — An experimental antibiotic has shown promise against a dangerous drug-resistant bacteria in animals, researchers report.

A combination of the new antibiotic TXA709 and the antibiotic cefdinir successfully treated animals infected with the so-called “superbug” MRSA — methicillin-resistant staphylococcus aureus.

The results are “important because even though TXA709 is effective on its own in treating MRSA, combining it with cefdinir — used to treat a wide range of bacterial infections like strep throat, pneumonia, bronchitis and middle ear and sinus infections — makes it even more efficacious, while also significantly reducing the potential for the MRSA bacteria to become resistant in the future,” said researcher Daniel Pilch. He’s an associate professor of pharmacology at Rutgers University Robert Wood Johnson Medical School, in Piscataway, N.J.

“What is also good about this experimental treatment is that both drugs can be taken orally, which means they can be administered on an outpatient basis. All but two of the current antibiotics being used clinically to treat MRSA need to be administered intravenously,” Pilch said in a university news release.

Pilch and others at Rutgers University developed the experimental antibiotic.

MRSA can cause a number of problems including skin infections, sepsis and pneumonia. MRSA infections result in 19,000 deaths a year and account for $3 billion in annual health care costs, the researchers said.

“Current standard-of-care drugs for the treatment of MRSA infections are limited,” Pilch said. “Furthermore, resistance to these drugs is on the rise, and their clinical effectiveness is likely to diminish in the future.”

Research on animals often fails to produce similar results in humans, so phase 1 clinical trials to test the safety and effectiveness of TXA709 in humans are expected to begin next spring.

The study is published in the July issue of the journal Antimicrobial Agents and Chemotherapy.

More information

The U.S. Centers for Disease Control and Prevention has more about MRSA.





from Health News / Tips & Trends / Celebrity Health http://ift.tt/1Xs2Yg6

Teen Obesity May Mean Liver Disease Later

THURSDAY, June 16, 2016 (HealthDay News) — Older teen boys who are overweight or obese could be at increased risk for severe liver disease later in life, a new study suggests.

The research included nearly 45,000 Swedish males who entered military service in their late teens between 1969 and 1970. The investigators reviewed over 40 years of their health information. Nearly 400 of them were diagnosed with severe liver disease, the study authors said.

Men who were overweight or obese in their late teens were 64 percent more likely to develop severe liver disease compared with men who had a low normal weight in their late teens. The researchers said that worked out to a 5 percent increased risk for every one point increase in body mass index (BMI).

BMI is an estimate of body fat based on weight and height. Overweight is defined as a BMI above 25. Obesity is defined as a BMI above 30, according to the U.S. Centers for Disease Control and Prevention.

“It is difficult to identify individuals in the general population who have an increased risk for development of cirrhosis and severe liver disease later in life,” said lead investigator Dr. Hannes Hagstrom.

But Hagstrom, of the Center for Digestive Diseases at the Karolinska Institute in Stockholm, said it’s important to learn how to predict liver disease so that researchers can develop effective prevention programs. And one factor that has been linked to the worldwide increase in liver diseases is the increasing prevalence of overweight and obesity.

The study was published June 16 in the Journal of Hepatology.

The findings can’t prove a cause-and-effect link, but do suggest “that the increased risk of a high BMI for the development of severe liver disease later in life is already present from an early age,” Hagstrom said in a journal news release.

“It is possible that this increased risk is caused by a longer exposure to being overweight, compared to becoming overweight or obese later in life, and that individuals with a longer history of being overweight have an increased risk of severe liver disease,” he explained.

More information

The American Liver Foundation has more about liver disease.





from Health News / Tips & Trends / Celebrity Health http://ift.tt/1Xs3P06

Extensive Surgery Best for an Aggressive Brain Cancer: Study

THURSDAY, June 16, 2016 (HealthDay News) — When it comes to battling a particularly aggressive form of brain tumor, more extensive surgeries may be best to boost patient survival, researchers have concluded.

The brain cancer — called glioblastoma multiforme — is often treated with surgery, radiation therapy and chemotherapy. However, the ideal combination of treatments for this cancer isn’t clear.

One expert said glioblastoma surgeries are especially complicated.

“Since this tumor infiltrates normal brain and is often indistinguishable from it, it is difficult to know where the tumor ends and normal brain begins,” explained Dr. Raj Narayan, a neurosurgeon who reviewed the new study findings.

“Therefore, an aggressive effort to remove ‘all’ of the tumor runs the risk of causing increased neurological deficits such as paralysis and loss of speech,” said Narayan, who is chair of neurosurgery at North Shore University Hospital, in Manhasset, N.Y.

Current surgical options for glioblastomas include performing a minimally invasive biopsy; a more moderate surgery where not all the tumor is removed; or opening the skull in an attempt to remove all the visible cancer.

However, which approach works best for patients hasn’t been clear, said a team led by Dr. Michael Glantz of Penn State Milton S. Hershey Medical Center, in Hershey, Pa.

What is known is that total surgical removal of the tumor comes with a higher risk of injury to important surrounding structures in the brain, the researchers noted.

To help resolve the issue, Glantz’ team looked at data from 37 previous studies to get a better idea of which surgery might be best. These studies included more than 41,000 glioblastoma patients.

The researchers found that total tumor removal boosted the odds of one-year survival by 61 percent compared to the partial approach. Two-year survival was increased by 19 percent after total removal.

Both total and more moderate surgeries increased one- and two-year survival compared with biopsy alone, the study found.

Overall, the more extensive the surgery, the longer patients survived, according to the study. The researchers also found that people who had their tumor completely removed were more likely to have slower disease progression over one year.

The study was published online June 16 in the journal JAMA Oncology.

The evidence suggests that total removal may be a more effective option than partial removal plus biopsy, Glantz’ team said. It also shows that people who are newly diagnosed with this type of brain cancer should have the total removal surgery “when clinically feasible,” they added.

Another brain cancer specialist said the findings aren’t a big surprise.

“This study confirms what we had thought for a long time — the superiority of complete surgical removal over partial removal and biopsy,” said Dr. John Boockvar. He directs the Brain Tumor Center at Lenox Hill Hospital, in New York City.

For his part, Narayan said brain tumor surgery is an ever-evolving craft that seeks to balance the need for full tumor removal against possible damage to healthy brain tissue.

“Our technology to help with this balancing act is constantly improving, but is by no means perfect yet,” he said. “We constantly balance the desire to achieve as complete a removal as possible, with the conflicting priority of trying to give the patient the best quality of life during the time he or she has left.”

More information

The American Association of Neurological Surgeons has more on glioblastoma.





from Health News / Tips & Trends / Celebrity Health http://ift.tt/1Xs34nS

Want New Knowledge to Stick? Head Straight to a Workout

THURSDAY, June 16, 2016 (HealthDay News) — Exercising after you learn new things might help you remember them, a small study suggests.

But the workout has to be done within a specific time window, and it can’t be immediately after learning, Dutch researchers said.

Their study involved 72 people who learned a series of picture-location associations. The participants were then assigned to one of three groups: exercising immediately after the learning session; exercising four hours after learning, and not exercising at all.

The workout involved 35 minutes of interval training on an exercise bike at an intensity of up to 80 percent of the participants’ maximum heart rates.

The study volunteers returned two days later to see how much they remembered from what they had learned. They also had an MRI.

Those who exercised four hours after the learning session retained the new information better two days later than those who exercised immediately after learning or those who didn’t exercise at all.

The study was published June 16 in the journal Current Biology.

“[Our findings show] that we can improve memory consolidation by doing sports after learning,” researcher Guillen Fernandez said in a journal news release. Fernandez is with the Donders Institute for Brain, Cognition and Behaviour at Radboud University Medical Center, in the Netherlands.

It’s not clear how or why exercising a few hours after learning might help people retain new information. Previous research in animals found that exercise boosts levels of chemical compounds that improve memory consolidation, the researchers said.

“Our results suggest that appropriately timed physical exercise can improve long-term memory and highlight the potential of exercise as an intervention in educational and clinical settings,” Fernandez and his colleagues said.

More information

Harvard Health has more on exercise, memory and thinking skills.





from Health News / Tips & Trends / Celebrity Health http://ift.tt/1WOXPyA

Doctors’ Group Backs Later School Start Times

THURSDAY, June 16, 2016 (HealthDay News) — To help ease sleep deprivation among teens, the American Medical Association recommends that middle and high school classes should not start until 8:30 a.m.

The new policy, adopted at the annual meeting of the American Medical Association (AMA) in Chicago this week, also states that doctors need to educate parents, teachers, school officials and others about the importance of sleep for teens’ physical and mental health.

“Sleep deprivation is a growing public health issue affecting our nation’s adolescents, putting them at risk for mental, physical and emotional distress and disorders,” AMA board member Dr. William Kobler said in an association news release.

“Scientific evidence strongly suggests that allowing adolescents more time for sleep at the appropriate hours results in improvements in health, academic performance, behavior, and general well-being,” Kobler said.

Recent research shows that only 32 percent of American teens get at least eight hours of sleep on an average school night. The American Academy of Pediatrics recommends that teens aged 14 to 17 should get 8.5 to 9.5 hours of sleep per night for optimal health and learning.

Currently, nearly 10 percent of U.S. high schools start at or before 7:30 a.m., the AMA said.

“We believe delaying school start times will help ensure middle and high school students get enough sleep, and that it will improve the overall mental and physical health of our nation’s young people,” Kobler said.

“While implementing a delayed school start time can be an emotional and potentially stressful issue for school districts, families and members of the community,” Kobler added, “the health benefits for adolescents far outweigh any potential negative consequences.”

More information

The National Sleep Foundation has more about teens and sleep.





from Health News / Tips & Trends / Celebrity Health http://ift.tt/23en79s

1 in 13 Young Adults in U.S. Considered Suicide in Past Year

THURSDAY, June 16, 2016 (HealthDay News) — About one in 13 young adults in the United States had serious thoughts of suicide in 2013-2014, federal officials reported Thursday.

That rate of 7.4 percent translates into 2.6 million Americans between the ages of 18 and 25, researchers said.

“Suicide is one of the leading causes of death among young adults, and it is preventable,” said Kana Enomoto. She’s principal deputy administrator at the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA), which released the report.

“We need to reach out to young people with the message that help is at hand, and promote effective programs for saving lives by treating people at risk whenever and wherever they need it,” Enomoto added in an agency news release.

One expert said help is out there for the troubled, but more must be done.

“Breaking down barriers regarding mental health, improving access to mental health services, better parental involvement and increasing awareness of crisis intervention hotlines are all necessary,” said Dr. Robert Dicker. He helps direct child and adolescent psychiatry at Northwell Health in New Hyde Park, N.Y.

The new report is based on 2013-2014 federal data. The findings also show significant differences in rates of “serious suicidal thoughts” among young adults across various states.

Rates ranged from a high of 10.3 percent in New Hampshire to a low of 6.2 percent in Texas, the study found.

Other states with the highest rates were Alaska, Indiana, Michigan, Montana, Nevada, Ohio, Oregon and Utah. Some states with the lowest rates were Arkansas, Connecticut, Florida, Georgia, Kansas, Mississippi, New Mexico, South Carolina and the District of Columbia.

Why the differences? Dicker said that’s still uncertain.

“Perhaps it may be due to state differences in family fragmentation, differing rates of substance use, depression, economic issues impacting more in some states, differing access to treatment services,” he theorized.

Between 2012-2013 and 2013-2014, the national rate of serious suicidal thoughts among young adults remained about the same. The same was true in each state, with the exception of New Hampshire, where it rose from 8.4 percent to 10.3 percent, according to the report.

The report is “instrumental in highlighting the seriousness and prevalence of the problem,” said Jill Emanuele, a psychologist with the Child Mind Institute’s Anxiety & Mood Disorders Center in New York City.

“Effective mental health treatment and emergency services are available to young adults in need, as well as the population at large,” she stressed.

Still, young Americans could benefit from “expanded awareness and access to mental health services throughout the country,” Emanuele added.

According to the American Association of Suicidology, warning signs of an impending suicide include thinking or talking about killing oneself; increased abuse of alcohol or drugs; a sense of purposelessness or hopelessness; or withdrawal from friends, family or other social contacts.

Additional red flags are uncontrolled anger, recklessness or significant mood changes.

SAMHSA created the National Suicide Prevention Lifeline 1-800-273-TALK (Lifeline) to provide immediate help to people in crisis. It’s available 24 hours a day, seven days a week.

More information

The American Academy of Family Physicians offers advice on coping with suicidal thoughts.





from Health News / Tips & Trends / Celebrity Health http://ift.tt/1UeDfHo

Painkiller That Killed Prince Part of Dangerous Wave of New Synthetic Drugs

By Dennis Thompson
HealthDay Reporter

THURSDAY, June 16, 2016 (HealthDay News) — The recent overdose death of rock legend Prince has brought renewed focus on the dangers posed by synthetic opioids — laboratory-created narcotics tweaked by chemists to produce potentially lethal highs while skirting U.S. drug laws.

Prince Rogers Nelson, 57, died April 21 from an overdose of fentanyl, a drug often used to quell pain in cancer patients when traditional opioids prove ineffective.

Despite its legitimate medical uses, fentanyl has acquired a growing reputation as a dangerous street drug thanks to at least a dozen synthetic variants now available to users, according to the U.S. Drug Enforcement Administration (DEA).

And fentanyl is only one of numerous synthetic opioids and designer drugs now flooding the illicit drug market in the United States, DEA acting chief Chuck Rosenberg warned during a U.S. Senate hearing last week.

“We are trying to keep up with a picture that changes almost every day,” Rosenberg testified. “We’ve identified something like 400 new psychoactive substances over the last four or five years.”

Another synthetic opioid, U-47700, has been connected to at least 50 deaths nationwide, but is so new to the black market that the DEA has not yet moved to control it, according to the Associated Press.

Synthetic narcotics are dangerous because their potency can far outstrip traditional opioids. For example, fentanyl is 25 to 40 times more potent than heroin, and 50 to 100 times more potent than morphine, said Dr. Mitra Ahadpour. She is a medical officer with the Center for Substance Abuse Treatment in the U.S. Substance Abuse and Mental Health Services Administration.

Rosenberg testified that “fentanyl is so dangerous we’ve had to instruct our agents that if they touch it or inhale it accidentally, they can die.”

Several states reported sharp increases in overdose deaths caused by fentanyl and its analogs in 2014, a health advisory from the U.S. Centers for Disease Control and Prevention noted. Ohio reported 514 fentanyl-related deaths in 2014 compared to 92 in 2013, while Maryland had 185 fentanyl deaths in 2014 compared to 58 the year before.

Ahadpour explained that “if someone is not opioid-tolerant, and uses either pharmaceutical or illicit fentanyl, you have a very high increased chance of respiratory depression and dying. Their breathing slows down, it goes to shallow breathing, and then they stop breathing.”

There’s wide variation in the potency of these synthetic drugs, and often they are cut with other illicit drugs, Ahadpour added. A user might buy heroin not knowing that it has been cut with fentanyl to increase its potency.

Eleanor Artigiani, deputy director of policy and governmental affairs with the University of Maryland’s Center for Substance Abuse Research, said, “They may think they’re getting heroin, or they’re just buying a Xanax pill off the street, when it’s actually one of these other substances.”

Artigiani added, “From what I’ve been hearing recently, sometimes even the people selling these drugs don’t know exactly what’s in them either. It’s like Russian roulette, because you don’t really know what you’re getting or what effect it’s going to have on you.”

Toxicology tests concluded that Prince died from a fentanyl overdose, although the medical examiner’s report did not say whether the fentanyl was prescription or an illicit analog, CNN reported.

Designer drugs are typically based on medications that have been around for decades, Artigiani said.

Fentanyl was first created in Belgium in the late 1950s, the DEA says, while U-47700 was developed in the 1970s by the pharmaceutical company Upjohn as a potential alternative for morphine.

Black market drug makers come across the formula for a drug, and then tweak the molecule slightly so that it has the same effect on people but isn’t technically the same substance, Artigiani explained.

“There’s a journal article or a patent document or something that gets produced,” she said. “Illicit chemists find it and reproduce it or tweak the molecules to look for other kinds of things that aren’t illegal, that haven’t been scheduled yet.”

Other synthetic opioids on the streets include substances with names like W-18, AH-7921 and MT-45, according to Congressional testimony provided by James Hall, an epidemiologist with the Center for Applied Research on Substance Use and Health Disparities at Nova Southeastern University in Miami.

Illicit drug manufacturers also produce other categories of designer drugs besides synthetic opioids, Hall said, including synthetic versions of cannabinoids, stimulants and hallucinogens.

Nearly all synthetic opioids and other designer drugs are manufactured in China, U.S. National Drug Control Policy Director Michael Botticelli testified before the Senate.

The designer drugs enter the United States either through the mail or across the Mexican or Canadian border, he said, and often are sold at head shops and other retail stores.

State and federal lawmakers are reviewing legislation designed to improve response against new synthetic narcotics, Botticelli said, and the United States is leading discussions with international partners to improve the global response to these drugs.

But right now, law enforcement often is several steps behind the traffickers because U.S. laws aren’t flexible enough to quickly outlaw emerging drug analogs, Rosenberg told Congress.

“I almost feel each time I sign an administrative control regulation that I’m simply telling the bad guys, ‘Not this one any more. Move over here.’ And that’s what they do,” Rosenberg said. “For every one substance we’ve controlled, legislatively or administratively, there are 11 more out there that are uncontrolled.”

More information

For more on synthetic drugs, visit the U.S. Senate Committee on the Judiciary.





from Health News / Tips & Trends / Celebrity Health http://ift.tt/1UeCdLu

Baby Your Baby With Sunscreen

WEDNESDAY, June 15, 2016 (HealthDay News) — Be sure your summer plans include a big dose of sun protection for your baby’s thinner and more delicate skin, a pediatrician recommends.

The best way to protect babies is to avoid direct sun exposure, especially between 10 a.m. and 2 p.m., said Dr. Jay Joo, a pediatrician at UCLA Health.

If that’s not possible, then make sure the baby has a wide-brimmed hat and long pants and long-sleeved shirts made of lightweight materials. Sunglasses are a good idea, too, if the baby will wear them, Joo added in a news release from the University of California, Los Angeles.

A small amount of sunscreen can be applied to the hands and other exposed areas of skin on babies up to 6 months of age. Apply a tiny bit first to make sure the sunscreen doesn’t irritate their skin, he suggested.

Liberal amounts of sunscreen can be used on babies over 6 months of age and older children, Joo said.

Apply broad-spectrum sunscreen with an SPF of 30. Put the sunscreen on your baby at least 15 minutes before going outside, and reapply every two hours and after the baby swims or sweats, Joo said.

If your baby does get too much sun, a cool compress or a calamine or aloe-based lotion may help with the discomfort, Joo suggested.

More information

The Skin Cancer Foundation offers sun safety tips for infants, babies and toddlers.





from Health News / Tips & Trends / Celebrity Health http://ift.tt/1Q64Gl2

Easing Your Child’s Allergies

WEDNESDAY, June 15, 2016 (HealthDay News) — Up to 40 percent of children in the United States have nasal allergies, the U.S. Food and Drug Administration says.

These kids likely have persistent sneezing, along with a stuffy or runny nose. These symptoms — known as allergic rhinitis — are more likely to develop if one or both parents have allergies, the agency noted.

Nasal allergies can be caused by outdoor allergens such as plant pollens (seasonal allergies) or indoor allergens such as mold, dust mites and pet dander.

If your child has seasonal allergies, pay attention to pollen counts and try to keep him or her inside when pollen levels are high, the FDA suggests.

In the spring and summer, during the grass pollen season, pollen levels are highest in the evening. In the late summer and early fall, during ragweed pollen season, pollen levels are highest in the morning. Some molds may also be seasonal. For example, leaf mold is more common in the fall, the FDA said.

Besides monitoring pollen counts, it often helps to keep windows closed in the house and car and run the air conditioner.

There are over-the-counter and prescription medicines to treat allergies, but parents need to be particularly careful when giving these products to children, the FDA said. Allergy shots are another option.

“In the last 20 years, there has been a remarkable transformation in allergy treatments. Kids used to be miserable for months out of the year, and drugs made them incredibly sleepy. But today’s products offer proven approaches for relief of seasonal allergy symptoms,” said Dr. Jay Slater in an agency news release.

Slater is a pediatric allergist and director of the FDA’s Division of Bacterial, Parasitic and Allergenic Products.

More information

The American Academy of Family Physicians has more about allergic rhinitis.





from Health News / Tips & Trends / Celebrity Health http://ift.tt/1Q65N46

For Better Heart Care, Get a Pharmacist on Your Team

By Karen Pallarito
HealthDay Reporter

WEDNESDAY, June 15, 2016 (HealthDay News) — People with poorly controlled risk factors for heart disease could cut their chances of future trouble by having pharmacists help manage their care, new Canadian research suggests.

For the study, trained community pharmacists recruited people at high risk for heart attack and stroke. Half of the study participants received “medication therapy management” in tandem with a pharmacist and half received “usual” care.

After three months, people who received intensive services to help them meet treatment targets had a 21 percent lower risk of future heart events when compared with those who received usual care, the study found.

People receiving pharmacists’ care lowered their estimated future risk of heart disease by more than 5 percent from the beginning of the study to its conclusion three months later. There was little change in risk for those receiving usual care.

“Since the risk for [heart] events is so high, any reduction is a good one,” said study author Ross Tsuyuki, a professor of medicine at the University of Alberta. He added that “it is likely that we have underestimated the real reduction in risk,” since many risk factors for heart disease change slowly.

The study focused on reaching out to people with multiple risk factors, consulting with them, prescribing needed medicines and adjusting medication dosages.

Tsuyuki and his team believe the study may be the first large randomized trial of its kind.

Since cardiovascular disease is the leading cause of death in the United States and worldwide, such an intervention could have major public health benefits, the study authors concluded.

The report is published in the June 21 issue of the Journal of the American College of Cardiology.

Dr. Larry Weinrauch, a cardiologist and assistant professor at Harvard Medical School in Boston, said the study highlights problems with health care delivery, particularly for high-risk patients taking multiple medications.

“In the U.S., I think we ought to be looking at systems for picking up those patients [and delivering] better care to them,” he said.

Whether pharmacists or other health practitioners provide that care is less important, said Weinrauch, who wrote an editorial accompanying the study.

Tsuyuki said that while it will take “political will” to make the necessary changes, the United States could benefit from replicating this model of care.

“You could have about 400,000 pharmacists available to help with your number one killer,” he said.

Heart disease costs the United States an estimated $444 billion annually in health-care costs and lost productivity, the study authors noted.

Some U.S. pharmacists already manage people with chronic conditions and complex medication regimens. But it’s not routine because reimbursement opportunities are limited. Pharmacists, unlike doctors, are not considered “providers” of care under the federal Medicare statute and cannot bill the health program directly, the researchers said.

By contrast, pharmacists in Alberta, Canada, get reimbursed by the provincial health plan $100 to $120 a year for a comprehensive medication review and $20 to $25 for follow-up visits, Tsuyuki said.

For the study, pharmacists at 56 pharmacy-based clinics recruited 723 patients, who were randomly assigned to the intervention or usual care.

Some large and clinically significant improvements in individual risk factors emerged in the pharmacist-care group compared with the usual care control group, Tsuyuki noted.

People with high blood pressure had a 9.4 mm Hg reduction in systolic blood pressure — the top number in a blood pressure reading. An optimal systolic reading is 120 mm Hg or less. But, only 28 percent of the control group reached the recommended target, versus 51 percent of the pharmacist-care group, the study found.

Patients with diabetes in the pharmacist-care group dropped their hemoglobin A1c — an indicator of blood sugar levels — from 8.6 percent at the start of the study to 7.6 percent three months later. The goal is a reading of 7 percent or less. But only 25 percent of the control group achieved it, compared with 42 percent of patients receiving pharmacist care, the investigators found.

In addition, significantly more patients receiving pharmacist care reached the target for LDL, or “bad” cholesterol, than those in the control group (56 percent versus 46 percent).

The pharmacist-care group also had a 20 percent greater reduction in smoking compared to the control group, according to the report.

One limitation of the study was its short duration; pharmacists expressed concern over continuing to provide usual care to high-risk patients, the researchers said. After three months, control group members were invited to participate in the pharmacist-care program.

More information

The American Pharmacists Association has an explanation of medication therapy management.





from Health News / Tips & Trends / Celebrity Health http://ift.tt/1ZSh8Fc